These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2472467)

  • 1. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
    Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
    Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.
    Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD
    J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    Schlesinger JJ; Brandriss MW; Walsh EE
    J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus.
    Cammack N; Gould EA
    Virology; 1986 Apr; 150(2):333-41. PubMed ID: 2421479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
    Buckley A; Gould EA
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neurovirulence of different strains of yellow fever virus in mice.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():631-7. PubMed ID: 3958694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
    Lobigs M; Dalgarno L; Schlesinger JJ; Weir RC
    Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
    Schlesinger JJ; Walsh EE; Brandriss MW
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.
    Ryman KD; Ledger TN; Weir RC; Schlesinger JJ; Barrett AD
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1353-6. PubMed ID: 9191929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.